(800) 369-0899
(215) 569-4000

Contact Us Today



← Older posts Newer posts →

Clinical Trial Explores Family Predisposition

A new clinical trial by the National Cancer Institute (NCI) for mesothelioma patients and their families is open. This particular trial focuses on genetic predisposition to mesothelioma and ways to potentially alter this effect. An NCI investigator says this important, long-term study has implications not only for the patient, but for their family members. Early » Read More

FDA Approves New Treatment for Mesothelioma

Those diagnosed with mesothelioma have a new treatment option for the first time in 15 years. The Food and Drug Administration (FDA) recently approved a new first-line therapy that uses electric fields to treat tumors in combination with chemotherapy. The treatment, called Novocure, uses low-intensity alternating electric fields to specifically target and inhibit the replication » Read More

Machine Learning Leads to Earlier Mesothelioma Diagnosis

Early diagnosis is crucial for patients suffering from mesothelioma. Unfortunately, due to current diagnosis methods, an early diagnosis of mesothelioma is rare. However, new technology developed by Google artificial intelligence (AI) experts may be the solution the mesothelioma community needs. The technology, a new machine learning tool using AI, can identify the rare cancer before » Read More

Role of MicroRNAs in a Mesothelioma Diagnosis

One of the main difficulties in treating malignant mesothelioma is its tendency to exhibit symptoms when the disease has progressed too far for effective treatment. Researchers worked to detect biomarkers by analyzing blood samples from patients who have been exposed to asbestos, but there is still much work to be done. MicroRNAs are tiny molecules » Read More

← Older posts Newer posts →